HomeInsightsStock Comparison

Genomic Valley Biotech Ltd vs Shelter Infra Projects Ltd Stock Comparison

Genomic Valley Biotech Ltd vs Shelter Infra Projects Ltd Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

  • The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 28.43 as of 16 Mar 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 yearsThe P/E Ratio of Shelter Infra Projects Ltd changed from 3.7 on March 2021 to 22.3 on March 2025 . This represents a CAGR of 43.23% over 5 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 yearsThe Market Cap of Shelter Infra Projects Ltd changed from ₹ 3.27 crore on March 2021 to ₹ 5.18 crore on March 2025 . This represents a CAGR of 9.64% over 5 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The revenue of Shelter Infra Projects Ltd for the Dec '25 is ₹ 0.56 crore as compare to the Sep '25 revenue of ₹ 0.56 crore. This represent the decline of 0% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Shelter Infra Projects Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ -0.1 crore. This represent the decline of -100% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The net profit of Shelter Infra Projects Ltd changed from ₹ 0.25 crore to ₹ -0.03 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shelter Infra Projects Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Genomic Valley Biotech Ltd

  • Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
  • The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
  • Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
  • Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Shelter Infra Projects Ltd

  • Shelter infra Projects Limited (SPIL), formerly known as Central Concrete & Allied Products Limited was incorporated in 1972.
  • Later, there was a change in SIPL's ownership from 2009, when Ramayana Promoters Pvt.
  • Ltd. took over the ownership from the earlier promoters Chirantan Mukherjee and family.
  • Thereafter, the name of the Company was changed to Shelter infra Projects Limited from Central Concrete & Allied Products Limited on September 27, 2010. SPIL is a recognized name in the construction field competent in managing mega-dimensional projects involving design and construction related to Civil, Mechanical and Electrical Engineering.
  • The Company is engaged in the design and construction of projects related to civil, mechanical and electrical engineering primarily in India.

FAQs for the comparison of Genomic Valley Biotech Ltd and Shelter Infra Projects Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Shelter Infra Projects Ltd?

Market cap of Genomic Valley Biotech Ltd is 7 Cr while Market cap of Shelter Infra Projects Ltd is 5 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Shelter Infra Projects Ltd?

The stock performance of Genomic Valley Biotech Ltd and Shelter Infra Projects Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Shelter Infra Projects Ltd?

As of March 16, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹24.99. On the other hand, Shelter Infra Projects Ltd stock price is INR ₹14.58.

How do dividend payouts of Genomic Valley Biotech Ltd and Shelter Infra Projects Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Shelter Infra Projects Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions